CAPTRUST FINANCIAL ADVISORS - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 119 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,000
-50.0%
61
-59.9%
0.00%
Q4 2021$2,000
-33.3%
152
+25.6%
0.00%
Q3 2021$3,000
+200.0%
121
+142.0%
0.00%
Q2 2021$1,000500.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders